Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
This research demonstrates the synthesis of a mangicol sesterterpene, suggesting structural revisions with implications for bioactivity.
Isolated from the marine fungus Fusarium heterosporum, mangicols represent a new class of sesterterpenoids featuring unprecedented spirotetracyclic cores and notable bioactivities. Herein, we report the first asymmetric synthesis of a mangicol sesterterpene exploiting a domino carbopalladation-carbonylation, Conia-ene cyclization, and SmI₂-mediated reductive cyclization to establish the spiro-fused tetracyclic framework in a concise manner. Our findings suggest a stereochemical revision of the polyol side chain of the initially isolated mangicols.
Xie et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: